Combined preoperative thyroglobulin and ACR-TIRADS assessment: implications for fine-needle aspiration biopsy strategy and thyroid cancer diagnosis
| dc.contributor.author | Karahan, Dogu | |
| dc.contributor.author | Keskin, Lezan | |
| dc.contributor.author | Mete, Burak | |
| dc.date.accessioned | 2026-06-19T06:38:06Z | |
| dc.date.available | 2026-06-19T06:38:06Z | |
| dc.date.issued | 2026 | |
| dc.department | Malatya Turgut Özal Üniversitesi | |
| dc.description.abstract | Purpose: The aim of this study is to evaluate the relationship of Thyroglobulin (Tg) with the American College of Radiology Thyroid Imaging Reporting and Data System (ACR-TIRADS) and Bethesda and its correlation with malignancy. Materials and Methods: The study included 603 cases. Ultrasonography (US), fine needle aspiration biopsy (FNAB), Tg and anti-Tg results were evaluated retrospectively. Nodules were scored according to the ACR-TIRADS. FNAB results were evaluated according to the Bethesda. The relationship between Tg levels, ACR-TIRADS, and FNAB results was evaluated to determine the risk of thyroid malignancy. Results: The mean age of cases was 50.98 +/- 13.73 (min-max: 18-79). 85.1% of the patients were female. Tg was statistically significantly higher in malignant patients (Bethesda 6). In the ROC analysis, the optimum cut-off value for Tg in predicting malignancy was found to be 245 ng/dL. Mean Tg levels were statistically significantly higher in the TIRADS 4, 5 groups than in the TIRADS 2 and 3 groups. Conclusion: Results showed that Tg is elevated in thyroid nodular disease, especially in malignant nodules. The Tg levels increased in parallel with the ACR-TIRADS malignancy-risk score. If these results are supported by other studies, the evaluation of Tg together with ACR-TIRADS may make an additional contribution to the FNAB decision and the prediction of thyroid malignancies. | |
| dc.identifier.dergipark | 1780784 | |
| dc.identifier.doi | 10.17826/cumj.1780784 | |
| dc.identifier.endpage | 115 | |
| dc.identifier.issn | 2602-3032 | |
| dc.identifier.issn | 2602-3040 | |
| dc.identifier.issue | 1 | |
| dc.identifier.startpage | 105 | |
| dc.identifier.uri | https://doi.org/10.17826/cumj.1780784 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12899/5393 | |
| dc.identifier.volume | 51 | |
| dc.identifier.wos | WOS:001718639500009 | |
| dc.identifier.wosquality | Q4 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | |
| dc.publisher | Cukurova Univ, Fac Medicine | |
| dc.relation.ispartof | Cukurova Medical Journal | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_WOS_20260612 | |
| dc.subject | Thyroglobulin | |
| dc.subject | Acr-Tirads | |
| dc.subject | Fnab | |
| dc.subject | Thyroid Cancer | |
| dc.title | Combined preoperative thyroglobulin and ACR-TIRADS assessment: implications for fine-needle aspiration biopsy strategy and thyroid cancer diagnosis | |
| dc.type | Article |












